Contraception, Menorrhagia, Endometrial Hyperplasia, Estrogen Replacement Therapy
Conditions
Brief summary
Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy
Interventions
Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications
Exclusion criteria
* All patients with contraindications to Mirena insertion, according to approved prescribing information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient distribution per indication | 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Patient compliance | 12 months |
Countries
Kazakhstan
Outcome results
None listed